/OMDA
OMDA Stock - Omada Health
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$14.50+0.55%
+$0.08 (+0.55%) • Dec 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.11
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+103.4%upside
Target: $29.49
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for OMDA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.36 – $14.64
TARGET (TP)$29.50
STOP LOSS$13.34
RISK/REWARD1:12.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta5.58
52W High$28.40
52W Low$14.14
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $169.80M | $122.78M | $89.19M |
| Gross Profit | $102.88M | $69.97M | $42.79M |
| Gross Margin | 60.6% | 57.0% | 48.0% |
| Operating Income | $-43,654,000 | $-65,997,000 | $-72,350,000 |
| Net Income | $-47,137,000 | $-67,511,000 | $-72,518,000 |
| Net Margin | -27.8% | -55.0% | -81.3% |
| EPS | $-0.85 | $-1.21 | $-1.30 |
Company Overview
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
83%
Hold / Neutral
1
17%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
5 Bullish1 Neutral/Bearish
Price Targets
$24
Average Target
↑ 65.5% Upside
Now
$19
Low
$24
Average
$29
High
Based on 9 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 13th 2025 | BMO Capital Markets | Initiation | Outperform | $27 |
| September 5th 2025 | Robert W. Baird | Initiation | Neutral | $24 |
| July 1st 2025 | Evercore ISI | Initiation | Outperform | $21 |
| July 1st 2025 | Morgan Stanley | Initiation | Overweight | $25 |
| July 1st 2025 | JP Morgan | Initiation | Overweight | $19 |
| July 1st 2025 | Barclays | Initiation | Overweight | $21 |
| July 1st 2025 | Needham | Initiation | Buy | $23 |
| July 1st 2025 | Goldman | Initiation | Buy | $29 |
| July 1st 2025 | Canaccord Genuity | Initiation | Buy | $27 |
Earnings History & Surprises
OMDABeat Rate
100%
Last 2 quarters
Avg Surprise
+65.0%
EPS vs Estimate
Beats / Misses
2/0
Last 12 quarters
Latest EPS
$0.02
Q4 2025
EPS Surprise History
Q3 25
+10.0%
$-0.09vs$-0.10
Q4 25
+120.0%
$0.02vs$-0.10
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 5, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.10 | $0.02 | +120.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.10 | $-0.09 | +10.0% | ✓ BEAT |
Q2 2025 | May 9, 2025 | — | — | — | — |
Latest News
BMO Capital Initiates Coverage On Omada Health with Outperform Rating, Announces Price Target of $27
📈 PositiveBenzinga•Nov 13, 2025, 10:48 AM
Barclays Maintains Overweight on Omada Health, Raises Price Target to $29
📈 PositiveBenzinga•Nov 7, 2025, 03:43 PM•Also:
OMDA stock has given up its prior gain. Omada Health shares were trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
➖ NeutralBenzinga•Nov 7, 2025, 02:47 PM
Evercore ISI Group Maintains Outperform on Omada Health, Raises Price Target to $28
📈 PositiveBenzinga•Nov 7, 2025, 02:44 PM
Omada Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Nov 7, 2025, 12:15 PM
Needham Maintains Buy on Omada Health, Raises Price Target to $28
📈 PositiveBenzinga•Nov 7, 2025, 11:09 AM
UPDATE: Omada Health Q3 Adj. EPS $(0.02) Beats $(0.08) Estimate,
📈 PositiveBenzinga•Nov 6, 2025, 10:35 PM
Omada Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Nov 6, 2025, 10:22 PM
Omada Health To Launch New Option Of Prescribing And Medication Management Of Anti-obesity Medications Including GLP-1s
📈 PositiveBenzinga•Nov 6, 2025, 09:40 PM
Omada Health Raises FY2025 Sales Guidance from $235.000M-$241.000M to $251.500M-$254.500M vs $238.758M Est
📈 PositiveBenzinga•Nov 6, 2025, 09:20 PM
Omada Health Q3 EPS $(0.06) Beats $(0.13) Estimate, Sales $68.030M Beat $61.020M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 09:19 PM
Omada Health To Present Data On Its Behavior Change Program On Participants Currently Or Previously On Glp-1 Medications For Weight Loss
➖ NeutralBenzinga•Nov 4, 2025, 05:02 PM
Barclays Maintains Overweight on Omada Health, Raises Price Target to $28
📈 PositiveBenzinga•Oct 22, 2025, 04:25 PM•Also:
Omada Health Reports 63% Sustained Weight Loss Post-GLP-1s; Over 100K Members Supported Since Program Launch
📈 PositiveBenzinga•Sep 8, 2025, 01:04 PM
Baird Initiates Coverage On Omada Health with Neutral Rating, Announces Price Target of $24
➖ NeutralBenzinga•Sep 5, 2025, 11:13 AM
Omada Health stock rises on market debut
📈 PositiveSeeking Alpha•Jun 6, 2025, 04:10 PM
Frequently Asked Questions about OMDA
What is OMDA's current stock price?
Omada Health (OMDA) is currently trading at $14.50 per share. The stock has moved +0.55% today.
What is the analyst price target for OMDA?
The average analyst price target for OMDA is $29.50, based on 1 analyst.
What sector is Omada Health in?
Omada Health operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is OMDA's market cap?
Omada Health has a market capitalization of $0.84 billion, making it a small-cap company.
Does OMDA pay dividends?
No, Omada Health does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBCRX
BioCryst Pharmaceuticals, Inc.
$7.41
Mkt Cap: $1.6B
MAZE
Maze Therapeutics, Inc.
$41.71
Mkt Cap: $2.0B
OMCL
Omnicell, Inc.
$46.84
Mkt Cap: $2.2B
PGNY
Progyny, Inc.
$26.63
Mkt Cap: $2.3B
PHR
Phreesia, Inc.
$16.55
Mkt Cap: $1.0B
SDGR
Schrödinger, Inc.
$17.66
Mkt Cap: $1.3B
TDOC
Teladoc Health, Inc.
$7.23
Mkt Cap: $1.3B
TXG
10x Genomics, Inc.
$16.05
Mkt Cap: $2.0B
UFPT
UFP Technologies, Inc.
$229.40
Mkt Cap: $1.8B
XERS
Xeris Biopharma Holdings, Inc.
$7.34
Mkt Cap: $1.2B
Explore stocks similar to OMDA for comparison